🔗 Share this article

This year's prestigious award in medical science has been granted for revolutionary discoveries that illuminate how the immune system targets dangerous pathogens while protecting the body's own cells.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—share this honor.

Their research identified specialized "security guards" within the defense system that remove rogue defense cells capable of harming the organism.

The findings are now paving the way for innovative therapies for autoimmune diseases and malignancies.

These winners will divide a prize fund valued at 11 million SEK.

Decisive Findings

"Their work has been essential for understanding how the immune system operates and the reason we don't all develop serious autoimmune diseases," stated the head of the Nobel Committee.

This trio's research explain a fundamental question: In what way does the defense system protect us from numerous infections while keeping our own tissues unharmed?

Our body's protection system employs white blood cells that search for signs of infection, including pathogens and germs it has never encountered.

Such defenders employ sensors—called receptors—that are generated by chance in a vast number of variations.

That provides the immune system the ability to combat a wide array of invaders, but the unpredictability of the mechanism inevitably creates immune cells that can target the host.

Protectors of the Immune System

Researchers previously understood that a portion of these problematic white blood cells were eliminated in the thymus—the site where white blood cells mature.

This year's award recognizes the identification of regulatory T-cells—known as the body's "peacekeepers"—which patrol the body to neutralize any defenders that attack the body's own tissues.

It is known that this mechanism malfunctions in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel stated, "The discoveries have laid the foundation for a novel area of research and accelerated the development of innovative treatments, for instance for cancer and immune disorders."

In cancer, T-regs block the body from fighting the growth, so studies are aimed at reducing their numbers.

For self-attack disorders, trials are exploring boosting regulatory T-cells so the body is not being harmed. A comparable approach could also be effective in minimizing the risks of organ transplant failure.

Pioneering Studies

Prof Sakaguchi, of Osaka University, conducted tests on rodents that had their immune gland extracted, causing autoimmune disease.

He showed that introducing defense cells from healthy mice could stop the disease—suggesting there was a mechanism for blocking defenders from harming the body.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an inherited autoimmune disease in mice and people that resulted in the discovery of a genetic factor vital for how T-regs operate.

"Their pioneering research has revealed how the immune system is kept in check by regulatory T cells, stopping it from mistakenly targeting the healthy cells," said a leading biological science specialist.

"This work is a striking example of how basic biological study can have broad implications for human health."